Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | GUZMAN, JORGE |
| Género | Hombre |
| Área Principal WOS | Clinical Neurology; Neurosciences; Language & Linguistics; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Clinical Neurology | 6 |
| Neurosciences | 5 |
| Language & Linguistics | 1 |
| Linguistics | 1 |
| Literature, Romance | 1 |
| Scopus | #Pub |
|---|---|
| Language And Linguistics | 1 |
| Linguistics And Language | 1 |
| Literature And Literary Theory | 1 |
| Neurology (Clinical) | 1 |
| Neurology | 1 |
| SciELO | #Pub |
|---|---|
| Human Sciences | 1 |
| Autor | Género | # Pub |
|---|---|---|
| SOLER, BERNARDITA | Mujer | 6 |
| CRUZ-QUIROGA, JUAN PABLO | Hombre | 1 |
| GARCIA-NANNIG, LORENA DEL PILAR | Mujer | 1 |
| CARCAMO, C. | Mujer | 4 |
| VASQUEZ, MACARENA | Mujer | 1 |
| WEAVER, D. | Hombre | 1 |
| CARCAMO-RODRIGUEZ, CLAUDIA ANDREA | Mujer | 2 |
| URIBE-SAN MARTIN, REINALDO MOISES | Hombre | 6 |
| CIAMPI-DIAZ, ETHEL | Mujer | 5 |
| GALLEGUILLOS, L. | Mujer | 1 |
| GOIRY, LORNA GALLEGUILLOS | Mujer | 2 |
| JURGENSEN, LUKAS | Hombre | 1 |
| GUZMAN, IGNACIO | Hombre | 2 |
| GARCIA, L. | - | 1 |
| JURGENSEN, L. | Hombre | 1 |
| CIAMPI, E. | - | 1 |
| MARIN, J. | - | 1 |
| RAMIREZ, KARLA | Mujer | 2 |
| VERA, FRANCISCO | Hombre | 3 |
| PELAYO, CAROLINA | Mujer | 5 |
| PINTO, CLAUDIO | Hombre | 1 |
| CRUZ, JP. | Hombre | 1 |
| REYES, ANA | Hombre | 1 |
| GARCIA, LORENA | Mujer | 1 |
| Institución | # Pub |
|---|---|
| Pontificia Universidad Católica De Chile | 6 |
| Universidad De Chile | 2 |
| Hospital Del Salvador | 1 |
| Univ Cent Venezuela | 1 |
| Universidad Central De Venezuela | 1 |
| Hosp Salvador | 1 |
| Palabra Clave | #Pub |
|---|---|
| covid-19 | 1 |
| humoral response | 1 |
| inactivated virus | 1 |
| mrna | 1 |
| multiple sclerosis | 1 |
| sars-cov-2 | 1 |
| vaccine | 1 |